Improving thrombolysis with encapsulated plasminogen activators and clinical relevance to myocardial infarction and stroke

Clinical Hemorheology and Microcirculation

Volumn 30, Issue 3-4, 2004, Pages 225-228

  Leach, J Kent ^a,b,d   Patterson, Eugene ^c   O'Rear, Edgar A ^a,b,e  

^a University of Oklahoma   (United States)

^b University of OK   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; BLEEDING; BLOOD CLOT LYSIS; CAROTID ARTERY; CONFERENCE PAPER; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG DOSAGE FORM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG POTENCY; HEART INFARCTION; HEART VENTRICLE INFARCTION; HEART VENTRICLE SIZE; IN VIVO STUDY; MICROENCAPSULATION; NONHUMAN; PLASMINOGEN ACTIVATION; RABBIT; REPERFUSION; STATISTICAL SIGNIFICANCE; STROKE; THROMBOSIS; THROMBOSIS PREVENTION;

ANIMALS; BLOOD FLOW VELOCITY; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; RABBITS; THROMBOSIS;

EID: 3242658885     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. H.R. Andersen et al., for the DANAMI-2 Investigators, A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction, N. Engl. J. Med. 349 (2003), 733-742.
2. E.C. Keeley, J.A. Boura and C.L. Grines, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet 361 (2003), 13-20.
3. P.D. Nguyen, E.A. O'Rear, A.E. Johnson, E. Patterson, T.L. Whitsett and R. Bhakta, Accelerated thrombolysis and reperfusion in a canine model of myocardial infarction by liposomal encapsulation of streptokinase, Circ. Res. 66 (1990), 875-878.
4. Z.L. Li, N.Z. Zhang and Y.H. Nie, Accelerated thrombolysis by liposomal-encapsulated urokinase in a canine model of acute myocardial infarction, Chung Hua I Hsueh Tsa Chih 74 (1994), 338-340.
5. J.M. Heeremans, R. Prevost, M.E. Bekkers, P. Los, J.J. Emeis, C. Kluft and D.J. Crommelin, Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA, Thromb. Haemost. 73 (1995), 488-494.
6. W.R. Perkins, D.E. Vaughan, S.R. Plavin, W.L. Daley, J. Rauch, L. Lee and A.S. Janoff, Streptokinase entrapment in interdigitation-fusion liposomes improves thrombolysis in an experimental rabbit model, Thromb. Haemost. 77 (1997), 1174-1178.
7. J.K. Leach, E.A. O'Rear, E. Patterson, Y. Miao and A.E. Johnson, Accelerated thrombolysis in a rabbit model of carotid artery thrombosis with liposome-encapsulated and microencapsulated streptokinase, Thromb. Haemost. 90 (2003), 64-70.
8. B. Blombäck, Fibrinogen and fibrin - proteins with complex roles in haemostasis and thrombosis, Clin. Hemorheol. 16 (1996), 383-478.
9. J.K. Leach, Development and characterization of encapsulated thrombolytic formulations to enhance thrombolysis, University of Oklahoma, Ph.D. dissertation, 2003.
10. J.-H. Wu, K. Siddiqui and S.L. Diamond, Transport phenomena and clot dissolving therapy: An experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis, Thromb. Haemost. 72 (1994), 105-112.